Goel David E.

CIK 0001548144

Director10% Owner

Filings

Latest May 11, 2026

Issuers covered

Showing

8 of 8

Page 1

Track record

3 of 4 open-market trades scored (75% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

Horizon	Trades	Win rate	Avg	Median	Best	Worst
30 days	3	33%	-48.9%	-10.1%	+14.1%	-150.7%
90 days	3	33%	-33.6%	-21.1%	+14.0%	-93.6%
180 days	2	50%	-22.3%	-22.3%	+6.7%	-51.3%
365 days	2	50%	-13.3%	-13.3%	+55.0%	-81.6%

Issuers

Companies where Goel David E. has filed

Ticker	Issuer	Filings	Last filed
SLRN	Acelyrin, Inc.	2	May 23, 2025
ALMS	Alumis Inc.	2	May 23, 2025
AURA	Aura Biosciences, Inc.	2	May 11, 2026
ZNTL	Zentalis Pharmaceuticals, Inc.	2	Dec 15, 2025

All filings

8 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
May 11, 2026	AURAAura Biosciences, Inc.	SSale	6,922,870	$5.64	$39,044,987
Dec 15, 2025	ZNTLZentalis Pharmaceuticals, Inc.	SSale	7,500,000	$1.33	$9,975,000
May 23, 2025	ALMSAlumis Inc.	AGrant	4,493,741	-	-
May 23, 2025	SLRNAcelyrin, Inc.	DDisposition	9,334,735	$0.00	$0
Jul 3, 2024	ALMSAlumis Inc.	AGrant	2,500,000	$16.00	$40,000,000
Nov 9, 2023	AURAAura Biosciences, Inc.	PPurchase	1,560,000	$9.00	$14,040,000
Jun 20, 2023	ZNTLZentalis Pharmaceuticals, Inc.	PPurchase	4,760,000	$22.66	$107,861,600
May 11, 2023	SLRNAcelyrin, Inc.	CConversion	9,334,735	-	-

Showing 1-8 of 8

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value